CompoAtlas

Asportek BCAA

Natural health product licensed in Canada

Other names
AAB, Asportek AAB, BCAA
Licence holder
Asportek
NPN or DIN-HM
80058010
Status
Active licence
Licence date
6 February 2015
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Leucine1,500 milligrammeNot calculated
L-Isoleucine750 milligrammeNot calculated
L-valine750 milligrammeNot calculated
Sodium14.5 milligrammeNot calculated
Potassium18 milligrammeNot calculated
Magnésium3.2 milligrammeNot calculated

Non-medicinal ingredients

Saveur d'orange, Stévioside

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Mesures1 day

Uses authorised in Canada

Supplément à l'entraînement. Supplément athlétique. Source d'acides aminés essentiels et d'électrolytes pour le maintien d'une bonne santé. Source d'acides aminés branchés (AAB) essentiels jouant un rôle dans la synthèse des protéines, notamment les protéines musculaires. Aide à développer la masse musculaire/le tissu musculaire maigre lorsqu'utilisé en association avec un entraînement régulier en poids/en résistance et une diète équilibrée.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80058010

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line